Myriad Genetics Inc (MYGN)

Depreciation & Amortization

$50.20M

TTM · Period ending: · USD

MYGN logo

MYGN Depreciation & Amortization

Latest reported$50.20M
MYGN TTM Depreciation & Amortization ($1.90M → $50.20M)
High-resolution chart · PNG

MYGN depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
50,200,000
51,800,000
53,700,000
55,900,000
58,900,000
59,900,000
61,200,000
61,500,000
60,000,000
58,200,000
61,900,000
60,500,000
59,500,000
59,100,000
52,700,000
52,300,000
53,400,000
57,400,000
62,800,000
67,600,000
71,100,000
71,900,000
71,400,000
71,500,000
72,000,000
72,700,000
73,100,000
72,900,000
73,000,000
69,700,000
64,400,000
59,500,000
54,400,000
52,600,000
52,500,000
52,300,000
48,300,000
41,700,000
35,300,000
29,100,000
26,700,000
26,611,000
26,511,000
25,811,000
25,011,000
23,928,000
21,008,000
17,447,000
13,819,000
10,545,000
9,245,000
9,050,000
8,889,000
8,963,000
9,086,000
9,133,000
9,069,000
8,619,000
8,116,000
7,609,000
7,219,000
7,133,000
7,111,000
7,062,000
7,084,000
7,731,000
8,361,000
8,972,000
9,449,000
9,269,000
9,148,000
8,969,000
8,781,000
8,530,000
8,198,000
7,855,000
7,544,000
7,340,000
7,102,000
6,969,000
6,855,000
6,597,000
6,403,000
6,249,000
6,092,000
6,005,000
5,935,000
5,833,000
5,766,000
5,613,000
5,454,000
5,398,000
5,275,000
5,189,873
5,104,431
4,750,146
4,496,146
4,267,899
4,018,369
3,892,421
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.